RecruitingNot ApplicableNCT05306743

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

Pragmatic Evaluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD (PREVAIL)


Sponsor

Observational and Pragmatic Research Institute

Enrollment

126 participants

Start Date

Sep 23, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a quality improvement program called CONQUEST to help primary care teams better identify and treat high-risk patients with COPD (chronic obstructive pulmonary disease), a serious lung condition. The goal is to see whether this program improves care compared to the usual approach. **You may be eligible if...** - You are a primary care team (doctors, nurses, and staff working together) treating patients with COPD - Your team is willing to be randomly assigned to either use the CONQUEST program now or later - Your team has enough high-risk COPD patients to participate **You may NOT be eligible if...** - Your clinic is changing its electronic health record system or ownership during the study period - Your team is already participating in another COPD quality improvement or research program Note: This trial enrolls *healthcare teams*, not individual patients directly. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCONQUEST Quality Improvement Program

CONQUEST supports primary healthcare professionals to diagnose, assess, and optimize the management of their patients with modifiable high-risk COPD, through the promotion of guideline-based care. CONQUEST will promote management according to four "Quality Standards" for the care of modifiable high-risk COPD patients. The Quality Standards can be summarized as the timely and appropriate: Identification of high-risk patient groups for assessment; Assessment of disease and quantification of future risk; Non-pharmacological and pharmacological intervention; Follow-up. CONQUEST program will promote adherence to these standards through the use of electronic medical record -based algorithms for the identification of high-risk patients and clinical decision support resources. All decisions regarding patient management are made entirely at the discretion of the clinicians and patients who together negotiate the preferred course of action during consultations.


Locations(3)

University of Colorado

Denver, Colorado, United States

Mount Sinai

New York, New York, United States

MetroHealth

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05306743


Related Trials